DAVID HOOPER

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Nephrology CINCINNATI, OH NPI 1245284397

General Payments — all program years on this page

$32,135.20

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 24
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $24,633.76 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Alnylam Pharmaceuticals Inc. $18,803.0616
Kaneka Medical America LLC $5,750.001
NOVARTIS PHARMACEUTICALS CORPORATION $80.702

By program year

Program yearAmountRecords
2018 $20.911
2019 $12.121
2021 $2,700.001
2022 $4,768.412
2023 $24,633.7619

Records — PY2023 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1006130413 Alnylam Pharmaceuticals Inc. $94.18 04/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006130471 Alnylam Pharmaceuticals Inc. $116.00 04/29/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006130475 Alnylam Pharmaceuticals Inc. $396.77 04/25/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1006130479 Alnylam Pharmaceuticals Inc. $134.90 04/29/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1006130485 Alnylam Pharmaceuticals Inc. $134.90 05/01/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1006130489 Alnylam Pharmaceuticals Inc. $14.53 05/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006130495 Alnylam Pharmaceuticals Inc. $6,960.00 06/15/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
1006130655 Alnylam Pharmaceuticals Inc. $105.15 10/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006130659 Alnylam Pharmaceuticals Inc. $4,640.00 11/21/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
1006130665 Alnylam Pharmaceuticals Inc. $29.43 11/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006130715 Alnylam Pharmaceuticals Inc. $444.97 05/01/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1006130727 Alnylam Pharmaceuticals Inc. $4,640.00 11/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1006130731 Alnylam Pharmaceuticals Inc. $44.00 11/02/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1006130737 Alnylam Pharmaceuticals Inc. $91.68 11/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1006130741 Alnylam Pharmaceuticals Inc. $348.75 11/03/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1006130751 Alnylam Pharmaceuticals Inc. $607.80 11/02/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1060338135 Kaneka Medical America LLC $5,750.00 12/01/2023 Consulting Fee Undisputed 01/23/2026 View at CMS
992247549 Novartis Pharmaceuticals Corporation $33.99 05/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
992247553 Novartis Pharmaceuticals Corporation $46.71 06/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.